🇺🇸 Candesartan cilexetil / hydrochlorothiazide in United States

Candesartan cilexetil / hydrochlorothiazide (Candesartan cilexetil / hydrochlorothiazide) regulatory status in United States.

Marketing authorisation

FDA

  • Application: ANDA200887
  • Marketing authorisation holder: TEVA PHARMS USA
  • Local brand name: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Cardiovascular approved in United States

Frequently asked questions

Is Candesartan cilexetil / hydrochlorothiazide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Candesartan cilexetil / hydrochlorothiazide in United States?

TEVA PHARMS USA holds the US marketing authorisation.